St. Jude Medical announces advanced technologies for streamlined workflow in EP lab

NewsGuard 100/100 Score

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.

“Our streamlined EP Lab offerings provide advanced technologies that optimize interconnectedness and continue to move St. Jude Medical toward our ultimate goal of providing hospitals with fully integrated and networked EP labs.”

Millions of people worldwide are affected by abnormal heart rhythms, creating an ongoing need for diagnostic mapping and ablative technologies. The new product offerings from St. Jude Medical allow for a simplified diagnostic and treatment process, added safety and the potential for reduced treatment time for the patient.

"Improving procedural workflow is an important way to help improve efficiency and manage the cost of delivering care," said Jane J. Song, president of the St. Jude Medical Atrial Fibrillation Division. "Our streamlined EP Lab offerings provide advanced technologies that optimize interconnectedness and continue to move St. Jude Medical toward our ultimate goal of providing hospitals with fully integrated and networked EP labs."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revolutionizing brain tumor treatment: the rise of AI in neuro-oncology